Dr Reddy’s Teams Up With Kainomyx For Anti-Malarial Drug Development
Dr Reddy’s Subsidiary Aurigene Will Handle Drug Chemistry
Marking another step in Dr Reddy’s diverse corporate strategy, the company has signed a memorandum of understanding with Kainomyx for the development and commercialization of anti-malarials in multiple markets.
